Can I read SAVOR-TIMI 53 Trial Results on EtoBox?
SAVOR-TIMI 53 Trial Results by Ahmed Kamel is a document available to read on EtoBox.
What is SAVOR-TIMI 53 Trial Results about?
The SAVOR-TIMI 53 trial involved 16,492 patients with type 2 diabetes at risk for cardiovascular events, assessing the effects of saxagliptin versus placebo over a median follow-up of 2.1 years. The primary endpoint focused on cardiovascular death, myocardial infarction, or stroke, while secondary endpoints included various cardiovascular complications. The study concluded that saxagliptin did not affect ischemic event rates but increased hospitalization for heart failure, indicating the need for additional
- Author
- Ahmed Kamel
- Language
- EN